<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)</journal-id><journal-title-group><journal-title>Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)</journal-title></journal-title-group><issn publication-format="electronic">1990-472X</issn><publisher><publisher-name>Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">7840</article-id><article-id pub-id-type="doi">10.18499/1990-472X-2022-0-88-79-85</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>ТYPE 2 DIABETES MELLITUS THERAPY OPPORTUNITIES IN THE REPUBLIC OF BELARUS</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Sachek</surname><given-names>M. M</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kozhanova</surname><given-names>I. N</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Romanova</surname><given-names>I. S</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chak</surname><given-names>T. A</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff id="aff-1">Belarusian Medical Academy of Postgraduate Education</aff><aff id="aff-2">Belarusian State Medical University Dep. artment of Clinical Pharmacology</aff><pub-date date-type="epub" iso-8601-date="2022-09-28" publication-format="electronic"><day>28</day><month>09</month><year>2022</year></pub-date><issue>88</issue><fpage>79</fpage><lpage>85</lpage><history><pub-date date-type="received" iso-8601-date="2022-09-27"><day>27</day><month>09</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2022, Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)</copyright-statement><copyright-year>2022</copyright-year></permissions><abstract>Dynamic updating of international recommendations for the treatment of diabetes type 2 requires timely correction of national protocols and algorithms to ensure the quality of medical care. Material and methods. An analytical review of national regulatory documents regulating the treatment of patients with type 2 diabetes in the Republic of Belarus was carried out to determine the need for their correction. Results and discussion: Treatment of patients with type 2 diabetes in the Republic of Belarus is regulated by the national clinical protocol (CP). Type 2 diabetes is included in the list of diseases that give citizens the right to free provision of medicines (MP) issued by doctors' prescriptions within the List of Essential Medicines (EML) for outpatient treatment. Free provision of drugs for inpatient treatment is provided within the limits of the Republican Formulary of Medicines (RFL). The drugs included in the CP are partially not included in the EML and RFL and are not subject to state funding. Conclusions: the inclusion of drugs in the CP should contribute to the correction of restrictive lists that regulate the financing of pharmacotherapy. Timely correction of regulatory documents that define the treatment of type II diabetes, revision of the restrictive lists of drugs, taking into account new data on the effectiveness and economic opportunities of the healthcare system, will help expand the possibilities of pharmacotherapy and improve the quality of medical care for this category of patients.</abstract><kwd-group xml:lang="en"><kwd>diabetes type 2</kwd><kwd>regulatory documents</kwd><kwd>restrictive lists of medicines</kwd><kwd>Republic of Belarus</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>СД 2 типа</kwd><kwd>нормативные документы</kwd><kwd>ограничительные перечни лекарственных средств</kwd><kwd>Республика Беларусь</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Алгоритмы специализированной медицинской помощи больным сахарным диабетом / Под редакцией И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. - 10-й выпуск - М.; 2021 @@Algorithms of specialized medical care for patients with diabetes mellitus / Pod redaktsiyey I.I. Dedova, M.V. Shestakovoy, A.YU. Mayorova. - 10th release- М.; 2021</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Данилова, Л. И. Пути усовершенствования республиканского регистра «Сахарный диабет» / Л.И. Данилова, Е.Л. Богдан, А.А. Романовский. - Текст : непосредственный // Здравоохранение. - 2014. - № 11. - С. 4-5 @@Danilova, L. I. Ways to improve the republican register "Diabetes mellitus"/ L.I. Danilova, Ye.L. Bogdan, A.A. Romanovskiy. - Tekst : neposredstvennyy // Zdravookhraneniye.- 2014. - № 11. - С. 4-5</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>О внесении изменений в Приказ Министерства здравоохранения Республики Беларусь от 16 июля 2007 г. № 65: Приказ Министерства здравоохранения Республики Беларусь. Беларусь, 28 июня 2012 г., № 81 // КонсультантПлюс. Беларусь / ООО «ЮрСпектр», нац. центр правовой информации. Респ. Беларусь. - Минск, 2021. @@O vnesenii izmeneniy v Prikaz Ministerstva zdravookhraneniya Respubliki Belarusʹ ot 16 iyulya 2007 g. № 65: Prikaz Ministerstva zdravookhraneniya Respubliki Belarusʹ. Belarusʹ, 28 iyunya 2012 g., № 81 // KonsulʹtantPlyus. Belarusʹ / OOO «YurSpektr», nats. tsentr pravovoy informatsii. Resp. Belarusʹ. - Minsk, 2021.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Постановление Министерства здравоохранения Республики Беларусь 19 августа 2021 г. № 97 Об установлении Республиканского формуляра лекарственных средств на 2022 год. @@Postanovleniye Ministerstva zdravookhraneniya Respubliki Belarusʹ 19 avgusta 2021 g. № 97 Ob ustanovlenii Respublikanskogo formulyara lekarstvennykh sredstv na 2022 god.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Салко, О.Б. Итоги работы эндокринологической службы Республики Беларусь в 2021 году / О.Б. Салко - Текст : электронный. - URL: https://makaenka17med.by/respublikanskij-tsentr-endokrinologii/informatsiya-dlya-spetsialistov-endokrinologicheskoj-sluzhby/1565-itogi-raboty-endokrinologicheskoj-sluzhby-za-2021-god (дата обращения 08.04.2022) @@Salko, O.B Results of the work of the endocrinological service of the Republic of Belarus in 2021/ O.B. Salko - Tekst : elektronnyj. - URL: https://makaenka17med.by/respublikanskij-tsentr-endokrinologii/informatsiya-dlya-spetsialistov-endokrinologicheskoj-sluzhby/1565-itogi-raboty-endokrinologicheskoj-sluzhby-za-2021-god (дата обращения 08.04.2022)</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Adler, A. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64) / A. Adler, R. Stevens, S. Manley [et al.]. - Text : direct // Kidney Int. - 2003. - Vol.63. - P. 225-232</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>American Diabetes Association Professional Practice Committee. 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes-2022. - Text : direct // Diabetes Care. - 2022. - Vol.45(1). - P.125-143</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Danaei, G. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants / G. Danaei, M. Finucane, Y. Lu [et al.]. - Text : direct // Lancet. - 2011. - Vol. 378(9785). - P. 31-40</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Kirk, J. Predicted risk of coronary heart disease among persons with type 2 diabetes /j. Kirk, A. Bertoni, D. Case [et al.]. - Text : direct // Coron Artery Dis. - 2007. - Vol.18(8). - P.595-600</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Shaw, J. Global estimates of the prevalence of diabetes for 2010 and 2030 /j. Shaw, R. Sicree, P. Zimmet. - Text : direct // Diabetes Res Clin Pract. - 2010. -Vol.87(1). - P. 4-14</mixed-citation></ref></ref-list></back></article>
